EnVVeno Medical Corporation (NASDAQ:NVNO) | WebDisclosure

Basculer en Français

8302	Companies
115108	Keywords
55442	Articles
62528	Press releases

Headlines Articles Press releases EnVVeno Medical Corporation

Home
Companies
EnVVeno Medical Corporation

PRESS RELEASE

published on 09/03/2024 at 15:00, 2 months 18 days ago

enVVeno Medical Adds Sandy Prietto to its Executive Team as Vice President of Marketing
enVVeno Medical Corporation announces Sandy Prietto as new VP of Marketing, bringing significant MedTech marketing experience focused on Cardiovascular Devices. Company prepares for VenoValve monetization with upcoming milestones in 2024

VenoValve 2024 Milestones EnVVeno Medical Corporation Sandy Prietto VP Of Marketing
BRIEF

published on 08/14/2024 at 15:05, 3 months 7 days ago

EnVVeno Medical Updates on FDA Premarket Approval for VenoValve®

Medical Device FDA Approval EnVVeno Medical VenoValve CVI Treatment
BRIEF

published on 08/14/2024 at 15:05, 3 months 7 days ago

Mises à jour d'enVVeno Medical sur l'approbation préalable à la commercialisation de VenoValve® par la FDA

EnVVeno Medical Approbation De La FDA Dispositif Médical Valve VenoValve Traitement CVI
PRESS RELEASE

published on 08/14/2024 at 15:00, 3 months 7 days ago

enVVeno Medical Provides Update on FDA Premarket Approval Application Status for VenoValve(R)
enVVeno Medical Corporation provides update on VenoValve PMA approval application process for FDA. Company aims to file final module in Q4 2024 after approval of 4 modules

FDA VenoValve EnVVeno Medical Corporation PMA CVI
BRIEF

published on 08/01/2024 at 14:10, 3 months 20 days ago

EnVVeno Medical Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Financial Results FDA Approval Corporate Update Venous Disease VenoValve Trial
BRIEF

published on 08/01/2024 at 14:10, 3 months 20 days ago

EnVVeno Medical publie ses résultats financiers du deuxième trimestre 2024 et fait le point sur son entreprise

Résultats Financiers Mise À Jour De L'entreprise Approbation De La FDA Maladie Veineuse Essai VenoValve
PRESS RELEASE

published on 08/01/2024 at 14:05, 3 months 20 days ago

enVVeno Medical Reports Second Quarter 2024 Financial Results and Provides Corporate Update
enVVeno Medical Corporation reported financial results and clinical program updates for Q2 2024, including positive VenoValve trial data and progress on enVVe valve launch. Cash balance of $39.1M to fund operations till 2025

Financial Results Cash Balance VenoValve EnVVeno Medical Corporation EnVVe Valve Launch
BRIEF

published on 06/25/2024 at 15:05, 4 months 26 days ago

EnVVeno Medical participera à la série virtuelle de clôture des investisseurs

EnVVeno Medical VenoValve Maladie Veineuse Série Bell De Clôture Pour Investisseurs Virtuels Essai SAVVE
BRIEF

published on 06/25/2024 at 15:05, 4 months 26 days ago

EnVVeno Medical to Participate in the Virtual Investor Closing Bell Series

EnVVeno Medical VenoValve SAVVE Trial Venous Disease Virtual Investor Closing Bell Series
PRESS RELEASE

published on 06/25/2024 at 15:00, 4 months 26 days ago

enVVeno Medical to Participate in the Virtual Investor Closing Bell Series
Robert Berman, CEO of enVVeno Medical, to discuss positive venous ulcer healing data in upcoming live webcast. Learn about the VenoValve technology and company advancements

EnVVeno Medical VenoValve SAVVE Trial Robert Berman Venous Disease

Accesswire

Published on 11/21/2024 at 20:15, 1 hour 30 minutes ago

Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 1 hour 35 minutes ago

For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform
Published on 11/21/2024 at 20:00, 1 hour 45 minutes ago

Victory for New York Homeowners: Petroff Amshen LLP Blocks Lender’s Repeated Foreclosure Attempt
Published on 11/21/2024 at 19:25, 2 hours 20 minutes ago

Ibero Mining Reports Results From Deep Undercut Drill Hole At Miguel Vacas Mine
Published on 11/21/2024 at 17:35, 4 hours 10 minutes ago

1upHealth Ranked Number 43 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500(TM)

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 19:01, 2 hours 44 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 3 hours 9 minutes ago

Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 3 hours 47 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 3 hours 54 minutes ago

LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 3 hours 54 minutes ago

LIGHTON annonce le vif succès de son introduction en Bourse sur Euronext Growth Paris.

Les Echos

Published on 11/21/2024 at 06:58, 14 hours 47 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 14 hours 47 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 14 hours 47 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 1 day 1 hour ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 1 day 2 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE